<p>Syphilis, caused by <i>Treponema pallidum</i> (<i>T. pallidum</i>), represents a significant worldwide public health threat. This spiral-shaped, Gram-negative pathogen is a strict human-specific obligate parasite primarily transmitted through sexual contact. This pathogen induces a multistage and multisystem progressive disease, against which no effective prophylactic vaccine currently exists. This study focuses on syphilis prevention and control by employing a reverse vaccinology approach to investigate the immunogenic properties of <i>T. pallidum</i> adhesin proteins. Fifteen T-cell epitopes and seven B-cell epitopes were screened and linked in series using appropriate linkers to construct a multi-epitope vaccine. The vaccine was subjected to in silico analysis, including secondary and tertiary structure prediction, molecular docking, and molecular dynamics simulation. Based on these analyses, a recombinant plasmid, pET-28a(+)-MEVTP, was constructed, and the purified recombinant protein was obtained via nickel column affinity chromatography. In silico immune simulation results suggested that the vaccine could induce specific cellular and humoral immune responses. However, further experimental evaluation of its immunological effects is required to validate the computationally predicted immunogenicity, thereby establishing an experimental basis for its advancement toward translational medical applications and providing critical evidence to support syphilis prevention and control efforts.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Designing a novel multiepitope vaccine candidate against Treponema pallidum via adhesins using reverse vaccinology

  • Hongmei Tang,
  • Zhixi Chen,
  • Hongxia Yan,
  • Zhen He,
  • Ranhui Li,
  • Yafeng Xie,
  • Xiaoliu Wang

摘要

Syphilis, caused by Treponema pallidum (T. pallidum), represents a significant worldwide public health threat. This spiral-shaped, Gram-negative pathogen is a strict human-specific obligate parasite primarily transmitted through sexual contact. This pathogen induces a multistage and multisystem progressive disease, against which no effective prophylactic vaccine currently exists. This study focuses on syphilis prevention and control by employing a reverse vaccinology approach to investigate the immunogenic properties of T. pallidum adhesin proteins. Fifteen T-cell epitopes and seven B-cell epitopes were screened and linked in series using appropriate linkers to construct a multi-epitope vaccine. The vaccine was subjected to in silico analysis, including secondary and tertiary structure prediction, molecular docking, and molecular dynamics simulation. Based on these analyses, a recombinant plasmid, pET-28a(+)-MEVTP, was constructed, and the purified recombinant protein was obtained via nickel column affinity chromatography. In silico immune simulation results suggested that the vaccine could induce specific cellular and humoral immune responses. However, further experimental evaluation of its immunological effects is required to validate the computationally predicted immunogenicity, thereby establishing an experimental basis for its advancement toward translational medical applications and providing critical evidence to support syphilis prevention and control efforts.